Dr. Olle Melander and his colleagues at Lund University, Sweden have conducted a study to determine the association of proneurotensin, an amino acid peptide, on future risk of diabetes mellitus, cardiovascular disease, breast cancer, and death. Primarily expressed in the nervous system and gastrointestinal tract, little is known about neurotensin's role in development of breast cancer or cardiometabolic disease. Dr. Melander's study indicates that, "exclusively in women, proneurotensin was related to incident diabetes, cardiovascular disease, breast cancer, total mortality, and cardiovascular mortality."
Click here to read more about this study and other feature articles in the November 2012 issue of Artemis, the John Hopkins Breast Center monthly newsletter.
No comments:
Post a Comment